Apparently, that "same old, same old" shareholder update has pushed my level of frustration with the SPL BoD to new highs...
And I thought I was a tough critic on management .... lol
So you think the pivot to address the market in India given its current overwhelming medical situation for COVID-19 sufferers outlined in the Shareholder Update is frustrating ?
Sure they still have to pull it off, but with Mundipharma already a distribution partner with an SPL7013 product, it shouldn't be that hard IMO during a pandemic killing thousands a day
DEP Enrollment Update, page-5
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $38.11K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20455 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 38876 | 3 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |